Clinical trial Recruiting at 1 site Observational Ages 18 and up

Next-generation spectral CT imaging data collection from clinical scans

Official title: Data Collection of New Spectral CT Imaging Method

Run by GE Healthcare · NCT07661706 · Data updated 2026-11-12

This study tests how a new spectral CT system performs when used in real patient scans at St. Luke’s University Hospital Network to help with regulatory submissions.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorGE Healthcare
Industry-sponsored
Locations1 site (Bethlehem, Pennsylvania)
StatusRecruiting
StartedDecember 19, 2025
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedAugust 26, 2026
Trial IDNCT07661706 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who are scheduled for a clinically indicated CT exam within the next 30 to 90 days at St. Luke’s University Health Network and can consent.

Probably not a fit

Patients unlikely to benefit include those not undergoing the targeted CT exams or those with contraindications to the study procedures or consent.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects imaging data from adults undergoing a clinically indicated CT exam within the St. Luke’s network, focusing on image quality and spectral CT parameters. The goal is to characterize performance of a next-generation spectral CT system in a real-world clinical setting. Data and analyses will inform regulatory submissions and potential future use of the technology. Participation requires consent and follows standard safety and inclusion criteria related to CT imaging and contrast use. GE Healthcare leads the project with no external collaborators and location-specific procedures at the Bethlehem, PA site.

Why it matters

Potential benefit: If successful, the study could support regulatory approval and broader adoption of the spectral CT system, potentially improving diagnostic capabilities.

How similar studies have gone: Previous research in spectral CT has demonstrated technical feasibility and diagnostic potential, but this particular data-collection effort is observational and focuses on regulatory-data preparation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Who are ≥18 years of age;
* Able to sign and date the informed consent form; AND,
* Who have in the past 90 days or will in the future 30 days of the investigational scan undergo a clinically indicated CT exam within the St. Luke's University Hospital Network of the neck, chest, abdomen, pelvis, or extremities.

Exclusion Criteria:

* Who are pregnant or lactating;
* Who were previously enrolled in this study;
* For planned contrast-enhanced investigational CT exams, anyone with known or suspected allergy to iodinated contrast agents;
* For planned contrast-enhanced investigational CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel;
* Who need urgent or emergent care;
* Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; OR,
* Who are unwilling to have GEHC personnel present for the CT exam.

Where it's running

  • St Luke's University Health Network
    Bethlehem, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Microplastics and nanoplastics in people with chronic coronary syndromes

    This study will test whether tiny plastic particles (micro- and nanoplastics) can be detected in the coronary blood of adults with suspected or known chronic coronary syndromes who are having coronary CT and invasive angiography.

    Recruiting at 2 sites Azienda Ospedaliera "Sant'Andrea" · Caserta and 5 other locations · NCT07291609

  • CT‑XPI: a contrast‑free CT method to map lung perfusion

    This trial will test whether a new contrast‑free, high‑frame‑rate CT method (CT‑XPI) can show lung perfusion better than standard CT scans in adults having a clinically indicated CT.

    Recruiting Phase 2 University of Wisconsin, Madison · Madison, Wisconsin · NCT07192133

  • Using lung ultrasound to diagnose ARDS in patients on mechanical ventilation

    This study is testing if lung ultrasound can help doctors quickly diagnose ARDS in patients on mechanical ventilation, comparing it to CT scans.

    Recruiting Tanta University · Tanta · NCT06971042

  • Improving predictions for transcatheter treatment of tricuspid valve issues

    This study is trying to see if using advanced scans can help doctors better predict how well catheter treatments will work for people with severe tricuspid valve problems.

    Recruiting Heart and Diabetes Center North-Rhine Westfalia · Bad Oeynhausen, North Rhine-Westphalia · NCT06951126

  • Using Angio-CT and MRI to Manage Chronic Musculoskeletal Pain

    This study is testing a new way to treat chronic musculoskeletal pain using a minimally invasive technique that combines advanced imaging to help patients who haven't found relief with standard treatments.

    Recruiting Tri-Service General Hospital (TSGH) · Taipei · NCT06509087

  • Comparing lung imaging techniques in infants

    This study is testing different lung imaging methods in infants to see which one best helps doctors understand lung problems like collapse or over-inflation.

    Recruiting Medical University of Vienna · Vienna · NCT04989439

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.